Navigation Links
The Future of GPCRs in Drug Discovery: Novel Technologies, Leading Companies, and Opportunities for Target Expansion
Date:11/8/2010

NEW YORK, Nov. 8, 2010 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

The Future of GPCRs in Drug Discovery: Novel technologies, leading companies, and opportunities for target expansion

http://www.reportlinker.com/p0201024/The-Future-of-GPCRs-in-Drug-Discovery-Novel-technologies-leading-companies-and-opportunities-for-target-expansion.html

G-Protein-coupled receptors (GPCRs) constitute the largest family of membrane receptors, and the pharmaceutical industry has targeted them to a greater extent than any other protein class. Despite the high revenues generated by branded drugs that are active at GPCRs, only a small fraction of the GPCR family has thus far been commercially exploited. Consequently, considerable scope exists for broadening the reach of drug discovery efforts to counteract the impending patent expiries of many of the best-selling GPCR-targeted drugs.

This report provides insight into how recent advances in the understanding of GPCR function are opening up new avenues for exploration, where the most promising opportunities lie, and which companies are best placed to advance their GPCR-based proprietary drug discovery technologies. The report begins with outlines of the current commercial status of drugs targeting GPCRs and the scientific basis of their action, offering an understanding of why the large majority of the receptor family has remained unexploited.

This is followed by discussion of the scientific developments enabling the pursuit of new appro
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Covance Reports Third Quarter Financial Results and Takes Actions to Strengthen Future Performance
2. Saudi Arabias King Abdullah International Research Center Signs With Varian Medical Systems and IMRIS for Future Technology for Use in Radiotherapy
3. Media Statement From Amedisys on Dr. Steven H. Landers NEJM Commentary on the Future of Home Care
4. Reportlinker Adds Lung Cancer Drug Futures
5. Reportlinker Adds Prostate Cancer Drug Futures
6. Reportlinker Adds Renal Cell Carcimona Cancer Drug Futures
7. Sen. Harry Reid to Medco Employees: Technology and Innovation Integral to Sustainable Healthcare Reform and Nevadas Future
8. Interdisciplinary Convergent Approach May Represent Future for Treatment of Atrial Fibrillation
9. Lead Plaintiffs Attorney In Forest Pharmaceuticals Case Says $313 Million Award Is Tip of the Iceberg of Future Off-Label Marketing Lawsuits
10. Pharmaceutical Industry Insiders, VIPs All Coming Together for Future of Pharma Market, Pharmaceutical Competitive Intelligence
11. Reportlinker Adds Epigenetics: Current and future applications that are driving novel drug discovery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... -- Israel Brain Technologies (IBT) has announced the ... 1 st International Brain Technology Conference, which ... in Tel Aviv , recently ranked as ... by the Wall Street Journal and the epicenter ... showcase the latest breakthroughs in neuroscience and brain technology and ...
(Date:5/23/2013)... May 23, 2013 Halozyme Therapeutics, Inc. ... appointment of David A. Ramsay ... most recently Vice President, Corporate Development at Halozyme. ... "With his established financial management experience and ... working in our commercial group for the last ...
(Date:5/23/2013)... 2013  Omeros Corporation (NASDAQ: OMER ... Application (IND) to evaluate OMS824 in Huntington,s disease ... Drug Administration (FDA). OMS824 selectively inhibits phosphodiesterase 10 ... brain linked to a wide range of diseases ... OMS824 has shown promising results in animal models ...
Breaking Medicine Technology:Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 2Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 3Halozyme Therapeutics Names David A. Ramsay Chief Financial Officer 2Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 2Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 3Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 4
... Whenever someone needs high-quality drugs for less money, they are ... of the large choice of pharmacies, it may not be ... make things simpler and safer for anyone looking to buy ... website promotion is the responsibility of the renowned search ...
... 2011 /PRNewswire-Asia/ -- Winner Medical Group Inc. (Nasdaq: ... manufacturer of medical dressings, medical disposables and non-woven ... China, today announced that one of its subsidiaries, ... recently awarded a Cotton Processing Certificate by the ...
Cached Medicine Technology:New Online Pharmacy Rx-webmasters.com Allows Customers to Pay Less for High-Quality Drugs 2Winner Medical Obtains Cotton Processing Certificate from the State Development and Reform Commission 2Winner Medical Obtains Cotton Processing Certificate from the State Development and Reform Commission 3
(Date:5/23/2013)... May 23 (HealthDay News) -- Schools should ensure ... physical activity each day to support their health ... new report. Although previous studies show ... promotes health and development, it,s estimated that only ... meeting this recommendation, according to the report from ...
(Date:5/23/2013)... -- Symptoms of borderline personality disorder often mimic ... treatment. But researchers in Canada say they have ... borderline personality disorder: a tendency to misinterpret emotions ... difficulty processing facial emotions and will see a ... Ruocco, a clinical neuropsychologist and assistant professor at ...
(Date:5/23/2013)... HealthDay Reporter , , THURSDAY, May 23 (HealthDay News) -- ... badly as methamphetamine or crack cocaine, a new study ... mouth, or ,coke mouth, it is startling to see ... the same," said Dr. Mohamed Bassiouny, a professor of ... in Philadelphia. Methamphetamine, crack cocaine and soda -- ...
(Date:5/23/2013)... Although a study in 2012 suggested a cancer ... associated with Alzheimer,s disease, three groups of researchers ... those findings. The teams said their research ... the drug involved in the study, bexarotene (Targretin), ... abnormalities, pancreatitis, headaches, fatigue, weight gain, depression, nausea, ...
(Date:5/23/2013)... shown that an immune regulatory molecule called IL-21 is ... infections. , The results are published in the ... IL-21 could be important in the development of antiviral ... the first author of the paper. The senior author ... Center and a Georgia Research Alliance Eminent Scholar. , ...
Breaking Medicine News(10 mins):Health News:U.S. School Kids Should Get Hour of Exercise Daily: Report 2Health News:People With Borderline Personality Disorder May Misinterpret Facial Emotions 2Health News:People With Borderline Personality Disorder May Misinterpret Facial Emotions 3Health News:Diet Soda Habit as Bad for Teeth as Meth Addiction, Study Claims 2Health News:Diet Soda Habit as Bad for Teeth as Meth Addiction, Study Claims 3Health News:Scientists Can't Replicate Surprising Finding on Alzheimer's Treatment 2Health News:Vaccine blackjack: IL-21 critical to fight against viral infections 2
... Fox Chase Cancer Center and Geisinger Health System ... the translation of medical and health-related discoveries into ... part of the agreement, the three institutions will ... at Temple, to design and implement research on ...
... NEW YORK, Aug. 12 Care Investment Trust Inc.,(NYSE: ... finance company,investing in healthcare-related real estate and commercial mortgage ... manager, CIT,Healthcare that includes the following terms:, -- ... to purchase up,to $125 million of mortgage assets on ...
... to Increase Breast and ... Cervical Cancer Screening Rates, COLUMBIA, Md., ... guidance company, today announced the,launch of their Women,s Health and ... help increase the,prevention and early detection of breast and cervical ...
... Volume, but Lower Eyelids Get Fatter with Age, Study Finds , ... This study examined why lower eyelids get bulgy with age by ... (12 29 years old, 30 54, and 55 ... plastic surgeons discovered that while the rest of the face loses ...
... Precisely targeted radiation therapy can eradicate all evidence of ... to only a few sites, suggests the first published ... August 15, 2008, issue of Clinical Cancer Research, ... of Chicago Medical Center report that targeted radiation therapy ...
... (OTC Bulletin Board: DSKA) ("Duska") announced today that it ... (the "FDA"),Division of Cardiovascular and Renal Products on a ... lead drug, ATPace(TM), for the acute,treatment of a frequent ... 16, 2008, Duska met with the FDA and confirmed ...
Cached Medicine News:Health News:Temple, Fox Chase and Geisinger create Keystone Institute for Translational Medicine 2Health News:Care Investment Trust Inc. Announces an Agreement in Principle for CIT Healthcare to Purchase Mortgage Assets and Reduce Management Fee 2Health News:Resolution Health Introduces Women's Health and Wellness Action Campaign 2Health News:Resolution Health Introduces Women's Health and Wellness Action Campaign 3Health News:Resolution Health Introduces Women's Health and Wellness Action Campaign 4Health News:News briefs from the American Society of Plastic Surgery 2Health News:Targeted radiation therapy can control limited cancer spread 2Health News:Targeted radiation therapy can control limited cancer spread 3Health News:Duska Therapeutics Receives Comments From FDA on Phase 3 ATPace(TM) Protocol Synopsis 2Health News:Duska Therapeutics Receives Comments From FDA on Phase 3 ATPace(TM) Protocol Synopsis 3Health News:Duska Therapeutics Receives Comments From FDA on Phase 3 ATPace(TM) Protocol Synopsis 4
Solid 14 mm blades. Dull finish....
Angled for temporal approach. Open 14 mm rounded blades for patient comfort. Dull finish....
Open 14 mm blades of heavy 1 mm wire. Dull finish. Most popular size or model....
Open wire style blades allow complete manipulation of the phaco tip inside the eye. Lid control is excellent, exposure is maximized, and the likelihood of positive pressure is reduced....
Medicine Products: